With this in mind, we then analysed expression data for individual patients, and observed that 31% of all patients showed a reduction in MLH1 expression in tumour tissue in comparison to healthy tissue (log2fold change < -1) and 24% of patients displayed reduced expression of both MMR genes in neoplastic tissue (Figure 1B). This evidence concerns the gene MRC1 and neoplasm.